KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Cme (CME) Debt to Equity (2016 - 2025)

Historic Debt to Equity for Cme (CME) over the last 17 years, with Q3 2025 value amounting to $0.12.

  • Cme's Debt to Equity fell 8.63% to $0.12 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.12, marking a year-over-year decrease of 8.63%. This contributed to the annual value of $0.13 for FY2024, which is 102.43% up from last year.
  • Cme's Debt to Equity amounted to $0.12 in Q3 2025, which was down 8.63% from $0.12 recorded in Q2 2025.
  • Cme's 5-year Debt to Equity high stood at $0.13 for Q1 2021, and its period low was $0.12 during Q3 2025.
  • Moreover, its 5-year median value for Debt to Equity was $0.13 (2023), whereas its average is $0.13.
  • Within the past 5 years, the most significant YoY rise in Cme's Debt to Equity was 173.86% (2022), while the steepest drop was 455.59% (2022).
  • Over the past 5 years, Cme's Debt to Equity (Quarter) stood at $0.13 in 2021, then grew by 1.74% to $0.13 in 2022, then grew by 0.15% to $0.13 in 2023, then rose by 1.02% to $0.13 in 2024, then fell by 6.23% to $0.12 in 2025.
  • Its last three reported values are $0.12 in Q3 2025, $0.12 for Q2 2025, and $0.13 during Q1 2025.